期刊文献+

胸腺肽、干扰素辅助治疗毛细支气管炎 被引量:5

The Auxiliary treatment for bronchiolitis with thymic peptide and interferon.
下载PDF
导出
摘要 目的探讨胸腺肽、干扰素辅助治疗毛细支气管炎的临床疗效。方法对毛细支气管炎患儿223例,随机分为胸腺肽治疗组50例,干扰素治疗组67例,胸腺肽联合干扰素治疗组50例及对照组56例。对照组给予止咳平喘,普米克令舒加博利康尼雾化,退热,吸痰吸氧等综合治疗,治疗组在对照组基础上分别加用胸腺肽50mg/d,静脉滴注,疗程5d,-α2b干扰素50-100万U/d,肌肉注射,疗程5d,及联用胸腺肽和-α2b干扰素治疗。观察各组患儿主要临床症状体征恢复及住院时间。结果各治疗组的发热、喘憋、咳嗽、肺部干、湿音消失时间及住院时间均短于对照组(P〈0.05),胸腺肽联合干扰素治疗组疗效最佳(P〈0.05),而干扰素治疗组疗效又优于胸腺肽组。结论应用胸腺肽、干扰素辅助治疗毛细支气管炎,疗效显著,能缩短病程,尤其两药联用疗效更佳,值得临床推广。 Objective To explore the effect of thymie peptide, interferon on bronehiolitis. Methods 223 eases with bronehiolitis were randomly divided into four groups:50 eases in the thymie peptide treatment group,67 eases in the interferon treatment group,50 eases in the tymie pepide combined with interferon treatment group and 56 eases in the control group. The control group was treated with a comprehensive therapy of relieving cough and asthma, nebulization, defervescence, Aspirating sputum, oxygen uptaking, and the treatment group with thymie peptide(50mg/d iv gtt,5days) ,α-2b interferon(50 - 100 万U/d,im,5days) ,the two drug combination respectively in addition. The different recovery time of clinic symptom and physical signs was observed among the patients of four groups. Results The time need for the disappearance of fever, gasp,coughing,rales of chest and the hospitalization days of treatment group were significantly shorter than that of the control respectively( P 〈 0.05). That of drug combination group is the best,and interferon treatment group is better than that of thymie peptide group. Conclusion Tymie peptide,interferon is effective in treating bronehiolitis,and thymie peptide combined with interferon treatment is the best. It's worthy of extensive application for clinic work.
出处 《四川医学》 CAS 2008年第2期154-155,共2页 Sichuan Medical Journal
关键词 胸腺肽 干扰素 毛细支气管炎 thymie peptide interferon bronchiolitis
  • 相关文献

参考文献5

二级参考文献50

  • 1陈宗波,董永绥,赖丽霖.呼吸道合胞病毒急性下呼吸道感染患儿的细胞免疫变化[J].中华儿科杂志,1995,33(5):304-304. 被引量:4
  • 2聂青和,张久聪,闫英琪.胸腺素α1治疗慢性丙型肝炎的临床荟萃分析[J].实用肝脏病杂志,2005,8(6):346-351. 被引量:7
  • 3聂青和,张久聪.胸腺肽α_1单用治疗慢性乙型肝炎的临床荟萃分析[J].中国实用内科杂志,2006,26(3):382-386. 被引量:19
  • 4张符光,刘佃辛.胸腺和胸腺素研究进展[J].国外医学(免疫学分册),1996,19(4):187-191. 被引量:21
  • 5符州 李成荣 等.毛细支气管炎患者细胞因子异常与发病机理研究[J].中华微生物学和免疫学杂志,1998,18(1):57-57.
  • 6Sen GC.Viruses and intefferons.Annu Rev Microbiol,2001,55:255-281.
  • 7Biron CA,Nguyen KB,Pien.GC,et al.Natural killer cells in antiviral defense:function and regulation by innate cytokines.Annu Rev Immunol,1999,17:189-220.
  • 8Siegal FP,Kadowaki N,Shodell M,et al.The nature of the principal type 1 interferon-producing cells in human blood.Science,1999,284(5421):1835-1837.
  • 9Diebold SS,Montoya M,Unger H,et al.Viral infection switches nonplasmacytoid dendritic cells into high interferon producers.Nature,2003,424(6946):324-328.
  • 10Barnes BJ,Moore PA,Pitha PM.Virus-specific activation of a novel interferon regulatory factor,IRF-5,results in the induction of distinct interferon alpha genes.J Biol Chem,2001,276(26):23382-23390.

共引文献111

同被引文献29

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部